Epoprostenol

Indication

• Intravenous treatment of NYHA Class III/IV PPH and PAH associated with scleroderma

Risks

• Trauma and pneumothorax with catheter placement

• Local site infection & sepsis

• Thromboembolic events related to catheter

• Cardiovascular collapse

Previous slide

Next slide

Back to first slide

View graphic version